Dysregulated nephrin in diabetic nephropathy of type 2 diabetes: A cross sectional study

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Jim, Belinda ^a   Ghanta, Mythili ^a   Qipo, Andi ^a   Fan, Ying ^b   Chuang, Peter Y ^c   Cohen, Hillel W ^a   Abadi, Maria ^a   Thomas, David B ^d   He, John Cijiang ^c,e  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d Nephrocor   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; NEPHRIN; PODOCIN; SYNAPTOPODIN; BIOLOGICAL MARKER; MEMBRANE PROTEIN;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETIC NEPHROPATHY; DOWN REGULATION; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; MACROALBUMINURIA; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; PROTEINURIA; SYSTOLIC BLOOD PRESSURE; BLOOD PRESSURE; CASE CONTROL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY;

BIOLOGICAL MARKERS; BLOOD PRESSURE; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE PROTEINS; MIDDLE AGED;

EID: 84861211354     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0036041     Document Type: Article

References (36)

1. Reutens AT, Atkins RC, (2011) Epidemiology of diabetic nephropathy. Contrib Nephrol 170: 1-7.
2. Karalliedde J, Viberti G, (2010) Proteinuria in diabetes: bystander or pathway to cardiorenal disease? J Am Soc Nephrol 21: 2020-2027.
3. Stamm WE, Hooton TM, (1993) Management of urinary tract infections in adults. N Engl J Med 329: 1328-1334.
4. Bellinghieri G, Savica V, Santoro D, (2008) Renal alterations during exercise. J Ren Nutr 18: 158-164.
5. Haffner SM, Stern MP, Gruber MK, Hazuda HP, Mitchell BD, et al. (1990) Microalbuminuria. Potential marker for increased cardiovascular risk factors in nondiabetic subjects? Arteriosclerosis 10: 727-731.
6. Meyer TW, Bennett PH, Nelson RG, (1999) Podocyte number predicts long-term urinary albumin excretion in Pima Indians with Type II diabetes and microalbuminuria. Diabetologia 42: 1341-1344.
7. White KE, Bilous RW, Marshall SM, El Nahas M, Remuzzi G, et al. (2002) Podocyte number in normotensive type 1 diabetic patients with albuminuria. Diabetes 51: 3083-3089.
8. Nakamura T, Ushiyama C, Suzuki S, Hara M, Shimada N, et al. (2000) Urinary excretion of podocytes in patients with diabetic nephropathy. Nephrol Dial Transplant 15: 1379-1383.
9. Asanuma K, Mundel P, (2003) The role of podocytes in glomerular pathobiology. Clin Exp Nephrol 7: 255-259.
10. Kawachi H, Suzuki K, Miyauchi N, Hashimoto T, Otaki Y, et al. (2009) Slit diaphragm dysfunction in proteinuric states: identification of novel therapeutic targets for nephrotic syndrome. Clin Exp Nephrol 13: 275-280.
11. Otaki Y, Miyauchi N, Higa M, Takada A, Kuroda T, et al. (2008) Dissociation of NEPH1 from nephrin is involved in development of a rat model of focal segmental glomerulosclerosis. Am J Physiol Renal Physiol 295: F1376-1387.
12. Turk T, Leeuwis JW, Gray J, Torti SV, Lyons KM, et al. (2009) BMP signaling and podocyte markers are decreased in human diabetic nephropathy in association with CTGF overexpression. J Histochem Cytochem 57: 623-631.
13. Baelde HJ, Eikmans M, Lappin DW, Doran PP, Hohenadel D, et al. (2007) Reduction of VEGF-A and CTGF expression in diabetic nephropathy is associated with podocyte loss. Kidney Int 71: 637-645.
14. Wu Y, Dong J, Yuan L, Liang C, Ren K, et al. (2008) Nephrin and podocin loss is prevented by mycophenolate mofetil in early experimental diabetic nephropathy. Cytokine 44: 85-91.
15. Chen LP, Zhou QL, Peng WS, Wu XY, (2007) [Changes of podocyte ultrastructure and expression of podocyte-associated molecules in rats with diabetic nephropathy]. Zhong Nan Da Xue Xue Bao Yi Xue Ban 32: 620-625.
16. Langham RG, Kelly DJ, Cox AJ, Thomson NM, Holthofer H, et al. (2002) Proteinuria and the expression of the podocyte slit diaphragm protein, nephrin, in diabetic nephropathy: effects of angiotensin converting enzyme inhibition. Diabetologia 45: 1572-1576.
17. Doublier S, Salvidio G, Lupia E, Ruotsalainen V, Verzola D, et al. (2003) Nephrin expression is reduced in human diabetic nephropathy: evidence for a distinct role for glycated albumin and angiotensin II. Diabetes 52: 1023-1030.
18. Kelly DJ, Aaltonen P, Cox AJ, Rumble JR, Langham R, et al. (2002) Expression of the slit-diaphragm protein, nephrin, in experimental diabetic nephropathy: differing effects of anti-proteinuric therapies. Nephrol Dial Transplant 17: 1327-1332.
19. Faul C, Donnelly M, Merscher-Gomez S, Chang YH, Franz S, et al. (2008) The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat Med 14: 931-938.
20. Asanuma K, Kim K, Oh J, Giardino L, Chabanis S, et al. (2005) Synaptopodin regulates the actin-bundling activity of alpha-actinin in an isoform-specific manner. J Clin Invest 115: 1188-1198.
21. Huber TB, Hartleben B, Kim J, Schmidts M, Schermer B, et al. (2003) Nephrin and CD2AP associate with phosphoinositide 3-OH kinase and stimulate AKT-dependent signaling. Mol Cell Biol 23: 4917-4928.
22. Kestila M, Lenkkeri U, Mannikko M, Lamerdin J, McCready P, et al. (1998) Positionally cloned gene for a novel glomerular protein - nephrin - is mutated in congenital nephrotic syndrome. Mol Cell 1: 575-582.
23. Boute N, Gribouval O, Roselli S, Benessy F, Lee H, et al. (2000) NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat Genet 24: 349-354.
24. Patari A, Forsblom C, Havana M, Taipale H, Groop PH, et al. (2003) Nephrinuria in diabetic nephropathy of type 1 diabetes. Diabetes 52: 2969-2974.
25. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, et al. (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130: 461-470.
26. Bonnet F, Cooper ME, Kawachi H, Allen TJ, Boner G, et al. (2001) Irbesartan normalises the deficiency in glomerular nephrin expression in a model of diabetes and hypertension. Diabetologia 44: 874-877.
27. Benigni A, Zoja C, Corna D, Zatelli C, Conti S, et al. (2003) Add-on anti-TGF-beta antibody to ACE inhibitor arrests progressive diabetic nephropathy in the rat. J Am Soc Nephrol 14: 1816-1824.
28. Davis BJ, Forbes JM, Thomas MC, Jerums G, Burns WC, et al. (2004) Superior renoprotective effects of combination therapy with ACE and AGE inhibition in the diabetic spontaneously hypertensive rat. Diabetologia 47: 89-97.
29. Menne J, Meier M, Park JK, Boehne M, Kirsch T, et al. (2006) Nephrin loss in experimental diabetic nephropathy is prevented by deletion of protein kinase C alpha signaling in-vivo. Kidney Int 70: 1456-1462.
30. Kim JJ, Li JJ, Jung DS, Kwak SJ, Ryu DR, et al. (2007) Differential expression of nephrin according to glomerular size in early diabetic kidney disease. J Am Soc Nephrol 18: 2303-2310.
31. Toyoda M, Suzuki D, Umezono T, Uehara G, Maruyama M, et al. (2004) Expression of human nephrin mRNA in diabetic nephropathy. Nephrol Dial Transplant 19: 380-385.
32. Sever S, Altintas MM, Nankoe SR, Moller CC, Ko D, et al. (2007) Proteolytic processing of dynamin by cytoplasmic cathepsin L is a mechanism for proteinuric kidney disease. J Clin Invest 117: 2095-2104.
33. Coward RJ, Welsh GI, Koziell A, Hussain S, Lennon R, et al. (2007) Nephrin is critical for the action of insulin on human glomerular podocytes. Diabetes 56: 1127-1135.
34. Welsh GI, Hale LJ, Eremina V, Jeansson M, Maezawa Y, et al. (2010) Insulin signaling to the glomerular podocyte is critical for normal kidney function. Cell Metab 12: 329-340.
35. Ng DP, Tai BC, Tan E, Leong H, Nurbaya S, et al. (2011) Nephrinuria associates with multiple renal traits in type 2 diabetes. Nephrol Dial Transplant 26: 2508-2514.
36. Zheng M, Lv LL, Ni J, Ni HF, Li Q, et al. (2011) Urinary podocyte-associated mRNA profile in various stages of diabetic nephropathy. PLoS One 6: e20431.